3368-13-6 | 5-(Phenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide

Packsize	Purity	Availability	Price	Discounted Price
5mg	95%	1 week	$101.00	$71.00
10mg	95%	1 week	$136.00	$95.00
25mg	95%	1 week	$225.00	$158.00
50mg	95%	1 week	$315.00	$221.00
100mg	95%	1 week	$445.00	$311.00
200mg	95%	1 week	$632.00	$443.00

Description

• Catalog Number: AB43116
• Chemical Name: 5-(Phenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide
• CAS Number: 3368-13-6
• Molecular Formula: C8H8N4O4S3
• Molecular Weight: 320.3685
• MDL Number: MFCD01750412
• SMILES: O=S(=O)(c1ccccc1)Nc1nnc(s1)S(=O)(=O)N

Computed Properties

• Complexity: 503
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 19
• Hydrogen Bond Acceptor Count: 9
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 4
• XLogP3: 0.1

Literature

• Molecular cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Malassezia globosa, a potential antidandruff target.

  Journal of medicinal chemistry 20120412

• Cloning, characterization and sulfonamide inhibition studies of an α-carbonic anhydrase from the living fossil sponge Astrosclera willeyana.

  Bioorganic & medicinal chemistry 20120215

• Inhibition studies of the β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates.

  Bioorganic & medicinal chemistry 20110815

• Purification and inhibition studies with anions and sulfonamides of an α-carbonic anhydrase from the Antarctic seal Leptonychotes weddellii.

  Bioorganic & medicinal chemistry 20110315

• A new β-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth.

  Bioorganic & medicinal chemistry 20110201

• Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata.

  Bioorganic & medicinal chemistry letters 20110115

• Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis.

  Journal of medicinal chemistry 20100311

• T tubules and surface membranes provide equally effective pathways of carbonic anhydrase-facilitated lactic acid transport in skeletal muscle.

  PloS one 20100101

• Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c.

  Bioorganic & medicinal chemistry letters 20091201

• The taste of carbonation.

  Science (New York, N.Y.) 20091016

• Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides.

  Bioorganic & medicinal chemistry 20090715

• Carbonic anhydrase inhibitors. Inhibition and homology modeling studies of the fungal beta-carbonic anhydrase from Candida albicans with sulfonamides.

  Bioorganic & medicinal chemistry 20090701

• Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.

  Journal of medicinal chemistry 20090514

• Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate.

  Journal of medicinal chemistry 20090423

• Carbonic anhydrases CA4 and CA14 both enhance AE3-mediated Cl--HCO3- exchange in hippocampal neurons.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20090311

• Design of a carbonic anhydrase IX active-site mimic to screen inhibitors for possible anticancer properties.

  Biochemistry 20090217

• Carbonic anhydrase inhibitors: inhibition of the beta-class enzyme from the yeast Saccharomyces cerevisiae with sulfonamides and sulfamates.

  Bioorganic & medicinal chemistry 20090201

• CO2 chemosensing in rat oesophagus.

  Gut 20081201

• Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-ray crystallographic studies for the indapamide-isozyme II adduct.

  Bioorganic & medicinal chemistry letters 20080415

• Role of carbonic anhydrase IV in corneal endothelial HCO3- transport.

  Investigative ophthalmology & visual science 20080301

• Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides.

  Bioorganic & medicinal chemistry 20071201

• Combined effects of carbonic anhydrase inhibitor and adenosine A1 receptor antagonist on hemodynamic and tubular function in the kidney.

  Kidney & blood pressure research 20071101

• Endogenous alkaline transients boost postsynaptic NMDA receptor responses in hippocampal CA1 pyramidal neurons.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20070711

• Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.

  Bioorganic & medicinal chemistry letters 20070701

• Inhibition of hypoxia-induced calcium responses in pulmonary arterial smooth muscle by acetazolamide is independent of carbonic anhydrase inhibition.

  American journal of physiology. Lung cellular and molecular physiology 20070401

• Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.

  Journal of medicinal chemistry 20070125

• Pulmonary vasodilation by acetazolamide during hypoxia is unrelated to carbonic anhydrase inhibition.

  American journal of physiology. Lung cellular and molecular physiology 20070101

• Carbonic anhydrases and mucosal vanilloid receptors help mediate the hyperemic response to luminal CO2 in rat duodenum.

  Gastroenterology 20060701

• Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.

  Bioorganic & medicinal chemistry letters 20060415

• Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.

  Journal of medicinal chemistry 20060323

• Functional demonstration of surface carbonic anhydrase IV activity on rat astrocytes.

  Glia 20060201

• Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors.

  Journal of medicinal chemistry 20051201

• An investigation of the role of carbonic anhydrase in aquatic and aerial gas transfer in the African lungfish Protopterus dolloi.

  The Journal of experimental biology 20051001

• Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides.

  Bioorganic & medicinal chemistry letters 20050901

• Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?

  Bioorganic & medicinal chemistry letters 20050215

• Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.

  Bioorganic & medicinal chemistry letters 20050215

• Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.

  Bioorganic & medicinal chemistry letters 20041206

• Temporal adaptation of tubuloglomerular feedback: effects of COX-2.

  Kidney international 20041201

• Effect of carbonic anhydrase inhibition on GFR and renal hemodynamics in adenosine-1 receptor-deficient mice.

  Pflugers Archiv : European journal of physiology 20040901

• Benzolamide is not a membrane-impermeant carbonic anhydrase inhibitor.

  Journal of enzyme inhibition and medicinal chemistry 20040601

• Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with a topically acting antiglaucoma sulfonamide.

  Bioorganic & medicinal chemistry letters 20040503

• Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX.

  Journal of medicinal chemistry 20040422

• Carbonic anhydrase inhibitors: topically acting antiglaucoma sulfonamides incorporating esters and amides of 3- and 4-carboxybenzolamide.

  Bioorganic & medicinal chemistry letters 20030901

• Hemodynamics of early tubuloglomerular feedback resetting during reduced proximal reabsorption.

  Kidney international 20021201

• Carbonic anhydrase inhibitor sulthiame reduces intracellular pH and epileptiform activity of hippocampal CA3 neurons.

  Epilepsia 20020501

• Inhibition of muscle carbonic anhydrase increases rise and relaxation times of twitches in rat skeletal muscle fibres.

  Pflugers Archiv : European journal of physiology 20020301

• Extracellular carbonic anhydrase activity facilitates lactic acid transport in rat skeletal muscle fibres.

  The Journal of physiology 20010315

• Extracellular carbonic anhydrase in the dogfish, Squalus acanthias: a role in CO2 excretion.

  Physiological and biochemical zoology : PBZ 20010101

• Antifungal activity of Ag(I) and Zn(II) complexes of aminobenzolamide (5-sulfanilylamido-1,3,4-thiadiazole-2-sulfonamide) derivatives.

  Journal of enzyme inhibition 20000101

• Study of factors which modify the development of norepinephrine-induced acute renal failure in the dog.

  Kidney international 19790301